Related Experiment Video
Updated: Mar 29, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Hemophilia's Overlooked Female Face.
Alkistis Adramerina1, Marina Economou1
11st Pediatric Department, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Hippokration General Hospital, 546 42 Thessaloniki, Greece.
Female hemophilia carriers experience bleeding issues and are often underdiagnosed. Current healthcare practices need reevaluation to address their unique needs and improve management strategies for hemophilia in women.
Area of Science:
- Hematology
- Genetics
- Women's Health
Background:
- Hemophilia is increasingly recognized beyond a male-only disorder, with female carriers showing significant bleeding tendencies.
- Females can present with hemophilia severity similar to males, complicated by gynecological and obstetric bleeding.
- The term 'hemophilia carrier' historically implies normal hemostasis, leading to underdiagnosis and inadequate care for affected women.
Purpose of the Study:
- To highlight the underdiagnosed bleeding issues in female hemophilia carriers.
- To emphasize the need for reevaluation of diagnostic and treatment paradigms for women with hemophilia.
- To advocate for increased research and improved healthcare infrastructure for this patient population.
Main Methods:
- Review of current understanding of hemophilia in females.
- Analysis of factors contributing to underdiagnosis and inadequate treatment.
- Discussion of limitations in clinical trials and hemophilia center expertise.
Main Results:
- Female hemophilia carriers frequently experience overlooked bleeding symptoms.
- Gynecological and obstetric bleeding in females may not correlate with factor levels.
- Females with hemophilia are underrepresented in clinical research and often lack specialized care.
Conclusions:
- Established management practices for hemophilia require reevaluation to include females.
- Further research and larger studies are crucial to understand and address the needs of females with hemophilia.
- Improved infrastructure and expertise in hemophilia centers are necessary for effective female patient management.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
X-linked Traits
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Pedigree Analysis

